VIDEO – Empower Clinics Grows Revenue 416% To $USD 790,000 In Q1 – BEFORE COVID-19 Revenues Commenced In Q2

Sometimes, you just have to let the numbers speak for themselves.  With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for … but then these numbers came in for:   2019 – Year Ended DEC 31, 2019  Q4 – Quarter Ended DEC 31, 2019 Q1 – Quarter Ended MAR 31, 2020 Patient Visits 2019 +110% To 15,900 Q4 + 251% To 4,616 Q1 + 377% To 5,717 (PRE COVID REVENUES COMMENCING Q2) Revenues $USD 2019 + 86% To $2.03M Q4 + 217% To $625,000 Q1 + 416% To $790,000  (PRE COVID REVENUES COMMENCING Q2) Do you see a trend? We can’t wait for Q2 numbers (April, May, June) because we already know patient visits for April alone were up over 870%. Looking even further forward into Q3 (July, August, September), we  already know that July patient visits are going to set a record. Though CBDT had a very short cease trade order due to the delay in  getting these financials filed…. the wait was clearly worth it, as was  this interview with CEO, Steven McAuley,  who is Six Sigma certified  under the quality initiative of legendary GE (General Electric) Chairman  Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian  small cap markets. Never …. which explains how McAuley has been able to  guide Empower Clinics through the most disruptive retail environment in  recent history and turn it into significant growth. Watch this interview or listen by Podcast on Apple, Google, Spotify or your favourite podcaster.